Airnov Healthcare Packaging (previously Clariant Healthcare Packaging) will reveal its new visual identity and branding to industry partners along with its portfolio of specialty products that prevent packaged pharmaceuticals from degradation due to moisture and oxygen at the Pharmapack tradeshow. The event takes place at the Paris Expo, Porte de Versailles, Paris, France, from 5 to 6 February 2020.
Building upon a 65-years-plus legacy of delivering high-quality, plastic injection and packaging solutions, Airnov’s name reaffirms the mission of the company as it launches a new chapter in healthcare packaging. Specializing in active materials, functional design, and innovative plastic processing, the name combines the prefix “Air,” which emphasizes its core business of creating and manufacturing controlled atmosphere packaging, with the suffix “nov” that stands for innovation and novelty.
“Our new name, Airnov, harkens back to Süd-Chemie Airsec’s founding and the company’s history as a trusted partner for our customers. Our commitment to quality, safety, and compliance is why Airnov serves the majority of pharmaceutical companies worldwide. We see a bright future – one that builds on our strengths and expertise,” said Dr Matthias Brommer, president, and managing director, Airnov.
During Pharmapack, Airnov will present its full range of desiccant canisters and packets, oxygen scavengers, and odor adsorbers, along with its Advanced Desiccant Polymer (ADP) and EQius humidity stabilizers. It will also share how it is merging the stable and trusted foundation of the past and taking it forward with a fresh, modern outlook.
“The main driver of our forward-thinking vision is our increased agility to respond faster to the needs of our customers,” said Brommer. “We have three global research and development centers, as well as Arsenal Capital Partners’ healthcare industry expertise. We aim to leverage these resources to deliver sustainable and versatile packaging solutions.”
Formally Clariant Healthcare Packaging, Airnov was acquired by Arsenal Capital Partners, a leading private equity firm investing in specialty industrial and healthcare companies, in October 2019. The newly rebranded company is looking forward to sharing its exciting new vision and the start of conversations around innovation and customization with its customers and partners at Pharmapack (Stand J50) and on social media.